High neutralizing antibody titer in intensive care unit patients with COVID-19

Coronavirus disease 2019 (COVID-19) has a wide spectrum of disease severity from mild upper respiratory symptoms to respiratory failure. The role of neutralizing antibody (NAb) response in disease progression remains elusive. This study determined the seroprevalence of 733 non-COVID-19 individuals f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Li, To, Kelvin Kai-Wang, Chan, Kwok-Hung, Wong, Yik-Chun, Zhou, Runhong, Kwan, Ka-Yi, Fong, Carol Ho-Yan, Chen, Lin-Lei, Choi, Charlotte Yee-Ki, Lu, Lu, Tsang, Owen Tak-Yin, Leung, Wai-Shing, To, Wing-Kin, Hung, Ivan Fan-Ngai, Yuen, Kwok-Yung, Chen, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473321/
https://www.ncbi.nlm.nih.gov/pubmed/32618497
http://dx.doi.org/10.1080/22221751.2020.1791738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473321/
https://www.ncbi.nlm.nih.gov/pubmed/32618497
http://dx.doi.org/10.1080/22221751.2020.1791738

Ejemplares similares